Catalent's CEO Confirms Leadership Continuity As Novo Holdings Acquisition Nears
Express News | Catalent Inc - Alessandro Maselli to Remain President and CEO Post-Close
Express News | Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
Press Release: Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock
Weight loss drug expansion plan faces obstacles! Consumer groups in the USA demand the FTC to block the shareholders of novo-nordisk a/s from acquiring catalent.
On Thursday, consumer groups and two large unions in the usa urged the Federal Trade Commission (FTC) to block the acquisition contract of drug manufacturer catalent by novo-nordisk a/s shareholder Novo Holdings.